A Multicenter Phase II Study of Temozolomide Plus Disulfiram and Copper for Recurrent Temozolomide-Resistant Glioblastoma
Journal of Neuro-Oncology（2019）
Key words
Recurrent glioblastoma,Disulfiram,Temozolomide,Copper,Clinical trial
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined